ダウンロード数: 10053

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
56_11.pdf632.87 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author中村, 敏之ja
dc.contributor.author加藤, 春雄ja
dc.contributor.author牧野, 武朗ja
dc.contributor.author奥木, 宏延ja
dc.contributor.author岡崎, 浩ja
dc.contributor.alternativeNakamura, Toshiyukien
dc.contributor.alternativeKatou, Haruoen
dc.contributor.alternativeMakino, Takeakien
dc.contributor.alternativeOkugi, Hironobuen
dc.contributor.alternativeOkazaki, Hiroshien
dc.date.accessioned2010-01-27T05:31:14Z-
dc.date.available2010-01-27T05:31:14Z-
dc.date.issued2010-01-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/92996-
dc.description.abstractWe conducted a study of the symptoms of prostate cancer that required medical treatment in terminal patients intermittently hospitalized over a period of two years. We examined the medical records of 54 out of 55 patients who died of prostate cancer between January 2000 and December 2008. The period from the initial visit to death was between 6 and 179 months (median : 48 months). The frequency of hospitalization per patient within two years before death was between 0 and 12 times (median : 3 times). The leading causes of hospitalization (a total of 191 times) were pain (44 times), a poor physical condition (30 times), hematuria (23 times), cancer treatment (22 times), anemia (18 times), and urinary retention (12 times). Thirty-two cases required the use of opioids (0.5 to 25 months before death, median : 5 months), 25 cases required blood transfusion (0.5 to 24, median : 5 months), 17 cases required long-term catheterization (0.5 to 16, median : 4 months), 10 cases required external beam radiation (2 to 25, median : 15 months), 6 cases required percutaneous nephrostomy (0.5 to 7, median : 2 months), three cases required transurethral resection of the prostate (3 to 23, median : 23 months), and two cases required fracture fixation (5 to 6 months before death). Since urologists are in charge of patients from their initial visit to the terminal stage, they are required not only to immediately address, or prevent if possible, these symptoms appearing in the terminal stage, but also to help enhance the quality of life of patients by providing palliative care based on expert knowledge.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher泌尿器科紀要刊行会ja
dc.rights許諾条件により本文は2011-02-01に公開ja
dc.subjectProstate canceren
dc.subjectSymptoms of terminal patientsen
dc.subjectPalliative careen
dc.subject.ndc494.9-
dc.title前立腺癌による死亡前2年間に治療を必要とした症状の検討ja
dc.title.alternativeSymptoms of Prostate Cancer that Required Treatment in the Terminal Stage for Two Yearsen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume56-
dc.identifier.issue1-
dc.identifier.spage11-
dc.identifier.epage15-
dc.textversionpublisher-
dc.sortkey03-
dc.address邑楽館林医療事務組合館林厚生病院泌尿器科ja
dc.address邑楽館林医療事務組合館林厚生病院泌尿器科ja
dc.address群馬大学大学院医学系研究科泌尿器科学教室ja
dc.address邑楽館林医療事務組合館林厚生病院泌尿器科ja
dc.address邑楽館林医療事務組合館林厚生病院泌尿器科ja
dc.startdate.bitstreamsavailable2011-02-01-
dc.address.alternativeThe Department of Urology, Tatebayashi Kosei Hospitalen
dc.address.alternativeThe Department of Urology, Tatebayashi Kosei Hospitalen
dc.address.alternativeThe Department of Urology, Gunma University Graduate School of Medicineen
dc.address.alternativeThe Department of Urology, Tatebayashi Kosei Hospitalen
dc.address.alternativeThe Department of Urology, Tatebayashi Kosei Hospitalen
dc.identifier.pmid20104003-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.56 No.1

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。